A few hours ago, Facebook banned me (again) for posting my last article, which is due a follow-up. I’m often told lately, “That means you’re over the target,” so maybe that’s the article to push through the less censored email and media channels? Just sayin’.
I want to take a brief moment in looking back at the 20-month journey that led me to drop handling my lucrative trading accounts (up 25,000% in four years) and building my most recent education company—a model for networking educational services that would have fit perfectly into a world with several million new American homeschoolers—and focus on pandemic research, statistics, and analysis. I’ve lost a lot of friends over [not wanting to stand idly by during a medical and economic genocide], and spent over 130 days “in the box” over the past year on Facebook, where I built a community for sharing and analyzing research (which still exists, but is far less active since I shifted to this substack).
From May of last year, I read every paper and article I could find on hydroxychloroquine treatment research. I contributed a few to c19study.com, then gave a little advice to the site authors while they built hcqmeta.com in addition to a mild amount of proofreading (I’m dyslexic, but I spot a few things like mislabeled diagrams due to series insertions, and I can check a p-value on a simple binomial distribution just fine).
Today, as I checked Facebook to find out about my most recent ban, Facebook did its thing and reminded me of a post from 12 months ago. This is the image from that post.
The data here comes from five nations, and my spreadsheet included a national comparison where the 0.09% case fatality rate (CFR) among patients receiving hydroxychloroquine, azithromycin, and zinc was 98% lower than the case-weighted CFR of those five nations.
Even while I’m working on other projects and articles, I think back on this and how people who used to call me for mathematical or statistical consulting in all manner of fields (finance, liquefaction engineering, network analysis, materials engineering, and all manner of modeling problems) suddenly knew I was a deranged whacko quack. They could look at the chart above, compare it to the likely (ahem, very likely) fraudulent Surgisphere study or the how-is-this-not-designed-to-fail-and-deceive WHO study, and try to gaslight me or anyone communicating with me. And try to destroy relationships with and around me.
How does anyone ever decide that the efficacy of a medicine should not be judged by the examples of its most optimal usage? Do people lose faith in ibuprofen because it didn’t work when they shoved up their buttholes?
The Solution is Building Ba…
It’s almost as if the slogan was chosen as a motto for authoritarians to confuse people—maybe to tell them, “Let us do this for you…since you’re not capable of succeeding without us.” The brainwashing tactics are both that sophisticated and also that blunt. Building a better system is necessary at this point, and you should ask yourself what you’re doing to build an antifragile bridge into the next era.
As disturbed as I am by so much of what is going on in the world, I am also finding a million reasons to think that there is a great opportunity to invent a better world. I believe that after the collapse of the dollar, rough though the following years might be, the lack of enforceable intellectual property and other moat-building laws will lead to an explosion in new technology and a healthier environment of wealth accumulation. While medicine is being restricted after being prescribed by doctors—both by pharmacies and in hospitals—entrepreneurial physicians are at work building better systems.
The number of new friends I’ve made who seem to be moving in the direction of such a goal is extraordinary, and I fully expect to be working with some of them in the future. In fact, I’ve been raising money (successfully it seems, though I need to finish working out details with my lawyer before taking investment) to hire some of the incredible people I’ve worked with. I have even wondered if this could be a step toward a new form of research funding, amplified by the same millions of people supporting new media.
Dose Dependence in the Hydroxychloroquine Prophylaxis Research – The Chloroquine Wars Part LXXIV